We are live on ! Find out more
PWP

Private Wealth Partners Portfolio holdings

AUM $1.3B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+26.2%
3 Year Est. Return
+92.82%
5 Year Est. Return
+128.24%
10 Year Est. Return
+552.95%
AUM
$1.08B
AUM Growth
-$4.67M
Cap. Flow
-$18.1M
Cap. Flow %
-1.68%
Top 10 Hldgs %
51.4%
Holding
85
New
6
Increased
22
Reduced
36
Closed
5

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$6.97M
2
MRK icon
Merck
MRK
+$3.4M
3
DIS icon
Walt Disney
DIS
+$3.38M
4
CVX icon
Chevron
CVX
+$2.93M
5
K
Kellanova
K
+$1.65M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$15M
2
ATVI
Activision Blizzard
ATVI
+$14.9M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.89M
4
IMDX
Insight Molecular Diagnostics
IMDX
+$861K
5
T icon
AT&T
T
+$852K

Sector Composition

Rank Sector Weight
1 Technology 25.76%
2 Healthcare 20.92%
3 Financials 18.22%
4 Communication Services 14.91%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLTR icon
76
Palantir
PLTR
$315B
$241K 0.02%
+10,035
New +$245K
GO icon
77
Grocery Outlet
GO
$932M
$239K 0.02%
11,100
-14,650
-57% -$421K
MQY icon
78
BlackRock MuniYield Quality Fund
MQY
$810M
$194K 0.02%
+12,000
New +$201K
JPC icon
79
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$109K 0.01%
11,000
– –
CELG.RT
80
Bristol-Myers Squibb Rights
CELG.RT
$240M
$4K ﹤0.01%
20,000
– –
AAPL icon
81
PUT
Apple
AAPL
$4.95T
– –
-73,600
Closed -$12K
MSFT icon
82
PUT
Microsoft
MSFT
$2.89T
– –
-35,400
Closed -$2K
IMDX
83
Insight Molecular Diagnostics
IMDX
$152M
– –
-7,500
Closed -$861K
VRTX icon
84
Vertex Pharmaceuticals
VRTX
$122B
– –
-14,355
Closed -$2.89M
ATVI
85
DELISTED
Activision Blizzard
ATVI
– –
-155,710
Closed -$14.9M
1 2 3
4

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PR
Payden & Rygel Los Angeles, California $1.3B AUM 28.32% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Private Wealth Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Private Wealth Partners held 85 positions worth $1.08B, down 0.43% from $1.08B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Private Wealth Partners's Q3 2021 filing shows 6 new, 22 increased, 36 reduced and 5 closed positions. Its largest new stake was Freeport-McMoran: 197,860 shares worth $6.44M. The largest sale was Alibaba, an estimated $15M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Private Wealth Partners's largest Q3 2021 buy was Freeport-McMoran: 197,860 shares worth $6.44M.
  • Private Wealth Partners added most to Merck in Q3 2021, an estimated $3.4M increase.
  • Private Wealth Partners's biggest Q3 2021 reduction was Alibaba, cutting an estimated $15M.
  • Private Wealth Partners fully exited Activision Blizzard in Q3 2021, selling an estimated $14.9M.
  • Private Wealth Partners's ten largest holdings make up 51% of its $1.08B portfolio in Q3 2021.
  • Private Wealth Partners opened 6 new positions and closed 5 in Q3 2021.
  • Private Wealth Partners's portfolio value fell 0.43% quarter-over-quarter to $1.08B.

Based on Private Wealth Partners's 13F filing for Q3 2021, filed 12 Nov 2021.